|
FY2010
12 months to Dec 31, 2010
|
|
|---|---|
| REVENUES: | |
| Net sales | |
| Other revenues | |
| TOTAL REVENUES | |
| COSTS AND EXPENSES: | |
| Cost of sales | |
| Research and development | |
| Selling, general and administrative | |
| Change in fair value of contingent consideration | |
| Restructuring charges | |
| Acquired in-process research and development | |
| TOTAL COSTS AND EXPENSES | |
| INCOME FROM OPERATIONS | |
| OTHER INCOME (EXPENSE): | |
| Interest income | |
| Interest expense | |
| Change in fair value of investments | |
| Other income (expense), net | |
| TOTAL OTHER INCOME (EXPENSE) | |
| INCOME BEFORE INCOME TAXES | |
| INCOME TAX EXPENSE (BENEFIT) | |
| NET INCOME | |
| NET LOSS ATTRIBUTABLE TO NONCONTROLLING INTEREST | |
| NET INCOME ATTRIBUTABLE TO CEPHALON, INC. | |
| BASIC INCOME PER COMMON SHARE ATTRIBUTABLE TO CEPHALON, INC. (in dollars per share) | |
| DILUTED INCOME PER COMMON SHARE ATTRIBUTABLE TO CEPHALON, INC. (in dollars per share) | |
| WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING ATTRIBUTABLE TO CEPHALON, INC. (in shares) | |
| WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING-ASSUMING DILUTION ATTRIBUTABLE TO CEPHALON, INC. (in shares) |
Loading...
